Project Grant HT94252510071
Award Date
3/1/25
Completion Date
2/28/27
Dollars Obligated
$436K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19122, USA
Similar Awards
This federal Project Grant award of $1,585,000.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research at Temple University to target lymphatic chemokine signaling and promote lymphangiogenesis for the treatment of lymphedema. The 4-year award, starting on March 1, 2025 and ending on February 28, 2029, will enable the university to conduct advanced biomedical research focused on transforming healthcare for military...
This Project Grant award in the amount of $679,085.00 was issued by the Defense Health Agency, a component of the Department of Defense, under the Military Medical Research and Development program (CFDA 12.420). The funding supports research by Temple University-Of The Commonwealth System Of Higher Education, through its division Temple University, to investigate the role of tumor-associated sensory neurons in breast cancer invasion and metastasis. The award period runs from January 15, 2024...
The Defense Health Agency awarded Temple University a $434,492 Project Grant under the Military Medical Research and Development (CFDA 12.420) federal grant program to conduct research on "Mitochondrial Transplantation as a Novel Therapy for Lung Fibrosis". The award, with a performance period from June 1, 2025 to May 31, 2027, will support Temple University's efforts to explore innovative approaches to treating lung fibrosis, a chronic and debilitating respiratory condition. The...
This $434,499.00 federal Project Grant award from the Department of the Army's Military Medical Research and Development program (CFDA 12.420) supports the restoration of alveolar type II cell function in emphysema. The award was granted to Temple University-Of The Commonwealth System Of Higher Education, a prominent public research university in Philadelphia, Pennsylvania, to conduct this advanced biomedical research. The funding will be used for a 2-year period from September 1, 2025 to August...
Temple University-Of The Commonwealth System Of Higher Education received a $315,618 project grant award from the Defense Health Agency through the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from June 1, 2023 through May 31, 2025 examining the role of exosomes on the alveolar epithelium in idiopathic pulmonary fibrosis. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research...
This federal Project Grant award from the Defense Health Agency, under the Military Medical Research and Development (CFDA 12.420) program, provides $1,188,750.00 to Temple University-Of The Commonwealth System Of Higher Education to identify therapeutic peptide drugs for regenerating visual pathways. The 3-year award, effective from September 15, 2024 to September 14, 2027, supports advanced biomedical research focused on transforming healthcare for military service members and the broader...
The Defense Health Agency awarded Temple University a $1,999,996 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to identify diagnostic biomarkers of the cerebrovascular contributions to cognitive impairment in repeated blast concussion. The grant, awarded on June 1, 2025, supports advanced biomedical research focused on transforming healthcare for military service members and the public, with a performance period through May 31, 2029. This project...
The federal Project Grant award of $422,299.00 was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on February 1, 2025, supports research by Texas A&M University System Health Science Center (TAMU HSC) to study inhibiting renal lymphatic expansion to mitigate nephrotic syndrome. The research aims to develop innovative medical solutions addressing complex healthcare challenges relevant to military...
The Defense Health Agency awarded a $1,357,177 Project Grant titled "Promoting Self-Management in Head and Neck Cancer Survivors with Lymphedema and Fibrosis (PROMISE Trial)" to The Trustees of the University of Pennsylvania (Penn). This grant, provided under the CFDA Program 12.420 "Military Medical Research and Development", will fund research to compare the effects of in-person and telehealth lymphedema and fibrosis self-management programs versus usual care on symptom...
Temple University was awarded a $2.53 million Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research into the role of TRAF6 in primary alveolar epithelial cell injury from September 2021 through September 2025. As part of the Military Medical Research and Development program's goals to transform military and public health through innovative medical research, this project will...